Bard Access Systems, Inc.
Active in EUDAMEDUnited Statesfrom SRN EUDAMED FDA SRN US-MF-000017720 FEI 3006260740
Bard Access Systems, Inc. is a medical device manufacturer based in the United States, with 4,383 devices listed and 123 FDA recalls as of 12 Nov 2026.
- Devices
- 4,383
- Registrations
- EUDAMEDFDA
- FDA recalls
- 12319 ongoing
Registry facts
- Registries
- FDA GUDID 2,983
- EUDAMED 169
- Device classes
- FDA Class II 2,886
- FDA Class I 82
- EU Class I 16
- FDA Unclassified 11
- EU Class IIa 5
- Top EMDN categories
- FDA recalls
- Identifiers
- EUDAMED SRN US-MF-000017720
- FDA FEI 3006260740
- DUNS 044611812
At a glance
EU certificates
1 of 1 in force.
Market reach
- European Union
- EUDAMED actor, 1 certificate
- United States
- FDA FEI, FDA recalls
What Bard Access Systems, Inc. makes
Bard Access Systems, Inc. manufactures peripherally-inserted central venous catheters, including midline and hemodialysis variants, as well as vascular port administration sets and catheters. Their portfolio also includes vascular intervention infusion catheters, wearable percutaneous catheter/tube holders, and electrocardiographic/magnetic navigation systems for central venous catheter placement. Additionally, they produce general-purpose ultrasound imaging systems and accessories for vascular port needle insertion.
The company’s devices are classified under FDA’s Class I, Class II, and Unclassified (U) categories and are listed in the FDA’s Unique Device Identifier (UDI) database. Bard Access Systems, Inc. is based in the United States.
Catalogue
Search and filter all 4,383 devicesShowing 1-50 of 4,383
Company details
- EUDAMED SRN
- US-MF-000017720
- SRN (system / procedure pack)
- US-PR-000017870
- FDA FEI number
- 3006260740
- DUNS number
- 044611812
- EUDAMED status
- Active
- EUDAMED registered name
- Bard Access Systems, Inc.
- Registered address
- 605 North, 5600 West, 84116, Salt Lake City, United States
- Website
- No website
- Phone
- +1 801 230 5783
- PRRC contact
- Nitin Patil
EUDAMED certificates
1 certificate1 valid, 0 expiredMDR 1next expiry 6 Feb 2028
BSI Group The Netherlands B.V. 2797 1 certificate
- MDR 731186 Active
Quality management system EU MDR
- Issued
- 2 Sep 2026
- Expires
- 6 Feb 2028
- Reason
- Add device or group
FDA recalls
FDA recall records list 93 recalls initiated by Bard Access Systems, Inc., the earliest on 2003-09-23 and the most recent on 2026-08-10. By recorded status: 19 ongoing and 74 terminated. The reasons filed fall into these groups: labeling or instructions for use, sterility or contamination, packaging, electrical or power, mechanical integrity and manufacturing or quality process. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
Recalls initiated per year
- 2017 2
- 2018 0
- 2019 0
- 2020 0
- 2021 20
- 2022 1
- 2023 0
- 2024 0
- 2025 1
- 2026 17
2026
- 10 Aug 2026 Z-2984-2026 Class I Ongoing this is a downstream recall of class I recall RES 98777
Full distribution text
- 10 Aug 2026 Z-2985-2026 Class I Ongoing this is a downstream recall of class I recall RES 98777
Full distribution text
- 30 Jul 2026 Z-2872-2026 Class I Ongoing After placement of intraosseous (IO) needle sets, used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases, users may experience difficulty/inability to remove obturator, due to it locking to the needle hub, due to out-of-tolerance dimensions and IFU unclarity, which may result in new needle placement, which may result in delayed therapy
Full distribution text
- 21 May 2026 Z-2655-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2656-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2657-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2658-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2659-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2660-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2661-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 10 Aug 2026 Z-2984-2026 Class I Ongoing this is a downstream recall of class I recall RES 98777
Show the 25 most recent of 123 recalls
2026
- 21 May 2026 Z-2662-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2663-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2664-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2665-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2666-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2667-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2668-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
Full distribution text
- 21 May 2026 Z-2662-2026 Class II Ongoing Due to lidocaine ampoules being manufactured under deficient manufacturing practices by manufacturer, lidocaine ampoules are currently being recalled by supplier.
2025
- 11 Mar 2025 Z-1507-2025 Class I Ongoing Catheters indicated for short-or-long term access to the central venous system have tubing that exceeded melt flow index specification (higher), which could lead to increased material fatigue leaks, which could lead to infiltration, extravasation, discomfort, phlebitis, bleeding, air embolism, foreign body embolism, infection and interruption to therapy.
Full distribution text
- 11 Mar 2025 Z-1507-2025 Class I Ongoing Catheters indicated for short-or-long term access to the central venous system have tubing that exceeded melt flow index specification (higher), which could lead to increased material fatigue leaks, which could lead to infiltration, extravasation, discomfort, phlebitis, bleeding, air embolism, foreign body embolism, infection and interruption to therapy.
2022
- 20 Jun 2022 Z-1397-2022 Class I Ongoing BD Intraosseous Needle Kits may exhibit: 1) Increased force required to remove the stylet from intraosseous needle during placement may cause removal of the entire needle assembly and loss of intraosseous access; 2) Stylet safety mechanism may not engage as the stylet is removed; 3) Metal discs in the powered driver may stick rendering the driver unusable.
2021
- 19 May 2021 Z-1991-2021 Class II Terminated Catheter kits contained the incorrect micro-introducers.
- 19 May 2021 Z-1994-2021 Class II Terminated Catheter convenience kits contain the incorrect guidewire. Kits were labeled with 70cm guidewires, but contained a 50cm guidewire.
- 7 Apr 2021 Z-1652-2021 Class II Terminated Catheters contain two issues: 1. the inner diameter of the distal connector may be reduced resulting in inability to pass the catheter through the connector and 2. the catch slot on the distal connecter may be deformed resulting in the inability to properly lock
Full distribution text
- 7 Apr 2021 Z-1653-2021 Class II Terminated Catheters contain two issues: 1. the inner diameter of the distal connector may be reduced resulting in inability to pass the catheter through the connector and 2. the catch slot on the distal connecter may be deformed resulting in the inability to properly lock
Full distribution text
- 7 Apr 2021 Z-1654-2021 Class II Terminated Catheters contain two issues: 1. the inner diameter of the distal connector may be reduced resulting in inability to pass the catheter through the connector and 2. the catch slot on the distal connecter may be deformed resulting in the inability to properly lock
Full distribution text
- 7 Apr 2021 Z-1655-2021 Class II Terminated Catheters contain two issues: 1. the inner diameter of the distal connector may be reduced resulting in inability to pass the catheter through the connector and 2. the catch slot on the distal connecter may be deformed resulting in the inability to properly lock
Full distribution text
Frequently asked questions
How many devices does Bard Access Systems, Inc. have in the registry?
The registry currently lists 4383 devices for Bard Access Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bard Access Systems, Inc.'s devices?
Among its 50 most recently registered devices, Bard Access Systems, Inc. has devices listed in EUDAMED (48 devices) and FDA GUDID (2 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Bard Access Systems, Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Bard Access Systems, Inc.'s devices are Class I, Class IIa, Class II and Class III. Each device page shows its own class and authorisation.
Are there FDA recall records for Bard Access Systems, Inc.?
FDA recall records list 123 recalls initiated by Bard Access Systems, Inc., the most recent initiated on 10 Aug 2026. 19 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What EUDAMED certificates are recorded for Bard Access Systems, Inc.?
EUDAMED lists 1 certificate for Bard Access Systems, Inc. (quality management system) under MDR. The most recent was issued on 2 Sep 2026.
What are the newest devices from Bard Access Systems, Inc. in the registry?
The most recently registered devices listed for Bard Access Systems, Inc. include PowerPICC® Provena™ Catheter CK000909B, PowerPICC® Provena™ Catheter CK001006B, PowerPICC SOLO2 and Power PICC.